Inorganic materials for hemostatic modulation and therapeutic wound healing

a technology of inorganic materials and wound healing, which is applied in the direction of drug compositions, medical preparations, peptide/protein ingredients, etc., can solve the problems of excessive heat generated locally at the injured site, and achieve the effects of reducing the heat of hydration, and attenuating the side effects of tissue burning

Inactive Publication Date: 2009-07-23
RGT UNIV OF CALIFORNIA
View PDF18 Cites 58 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A major disadvantage to this product has been the excessive heat generated locally at the injured site as a consequence of the large enthalpy of hydration associated with the material currently marketed under the trade name, QuikClot® and distributed by Z-medica corporation of Wallingford, Conn.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inorganic materials for hemostatic modulation and therapeutic wound healing
  • Inorganic materials for hemostatic modulation and therapeutic wound healing
  • Inorganic materials for hemostatic modulation and therapeutic wound healing

Examples

Experimental program
Comparison scheme
Effect test

example 1

Formulations of Porous Inorganic Materials for Therapeutic Wound Healing

[0073]This example describes ion exchanged formulations of QuikClot® that reduce the heat of hydration by 5 to 40%. FIGS. 1A-1B show differential scanning calorimetry plots that demonstrate a reduced hydration enthalpy for the ion exchanged formulations. Formulations include mixtures of ion exchanged zeolite Linde Type A with inorganic salts including, but not limited to, calcium chloride (CaCl2) aluminum sulfate (Al2(SO4)3) and silver nitrate (AgNO3).

[0074]The hydration enthalpy of zeolites is related to the cations present in the zeolite (Yu, B L et al. Thermochimica Acta, 200 (1992) 299-308; Drebushchak, V A J Thermal Anal Calorimetry 58 (1999) 653-662; Mizota, T et al. Thermochimica Acta 266 (1995) 331-341). Typically, larger and less charged cations tend to have a lower hydration enthalpy. Additionally, the hydration enthalpy of a zeolite relative to the amount of water adsorbed has been found to decrease w...

example 2

Hemostatic Effects of Glass and Prehydration: Antibiotic Activity

[0078]This example describes a new class of materials (silaceous oxides and ceramics) which can be co-formulated with QuikClot® or applied directly alone for hemostatic efficacy. In addition, we have substantiated an antibiotic response from QuikClot® towards a typical Gram Negative bacteria.

The Glass Effect

[0079]QuikClot® is comprised of a dehydrated zeolite that is applied to the site of traumatic vascular hemorrhaging. At the time of contact with the blood, a large amount of heat is generated at the same time that the zeolite absorbs and sequesters fluid phase components from the blood matrix. It has been observed in our laboratory that, in addition to dehydration and heat generation, there is selective absorption of blood components to the zeolite surface as well as disruption of the local electrolyte concentration. Our initial understanding of the interaction between the four parameters: heat released upon hydrati...

example 3

Host-Guest Composites for Induced Hemostasis and Therapeutic Healing in Traumatic Injuries

[0087]In this example, two strategies for reducing the large amount of heat released by a zeolite-based hemostatic agent (HA) during application have been described and quantified: 1) ion exchange and 2) prehydration. Five ion-exchanged derivatives of the original HA have been prepared and assayed for hemostatic efficacy both in vitro, by TEG®, and in vivo, by clinical swine trials. Contact activation coagulation rates, α, were found to increase with the amount of heat released by the HA. In vitro clot induction time, R, and HA surface area have been identified as predictors of in vivo hemostatic performance. A proposed rationale for selecting hemostatic materials based on these parameters will likely reduce the quantity of experiments involving animals, and the associated labor and capital costs, necessary to test a new HA. A method for incorporating antibacterial activity against gram negativ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides compositions, methods and devices relating to a silaceous oxide that generates a reduced heat of hydration upon contact with blood. By reducing the heat of hydration, the compositions provide a hemostatic agent that attenuates a tissue burning side effect of conventional hemostatic agents without adversely affecting the wound healing properties of the composition.

Description

[0001]This application claims the benefit of U.S. provisional patent application Ser. No. 60 / 668,022, filed Apr. 4, 2005, the entire contents of which are incorporated herein by reference.GOVERNMENT RIGHTS[0002]This invention was made with Government support under Grant No. N00014-04-1-0654, awarded by the Office of Naval Research. The Government has certain rights in this invention.TECHNICAL FIELD OF THE INVENTION[0003]The invention disclosed herein relates to compositions and methods for modulating the blood coagulation cascade, reducing the risk of microbial infection and promoting bone growth. Porous and nonporous high surface area small particle inorganic materials have been designed to treat traumatically injured tissue through rapid dehydration of a wound, promotion of blood clot formation, ion exchange with the tissue media for antibiotic and therapeutic activity, and controllable warming of the injured site.BACKGROUND OF THE INVENTION[0004]U.S. Pat. No. 4,822,349 issued to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K33/06A61P17/02A61P7/02A61K38/48A61K33/24
CPCA61K33/24A61K33/08A61K33/34A61K33/38A61K45/06A61K47/48961A61L26/0004A61L26/0061A61L2400/04B82Y5/00C03C1/006C03C3/097C03C4/0007C03C11/00C03C12/00A61K31/19A61K33/00A61K33/06A61K33/30A61K47/6949A61P17/02A61P43/00A61P7/02
Inventor STUCKY, GALEN D.OSTOMEL, TODD A.SHI, QIHUISTOIMENOV, PETER K.HOLDEN, PATRICIA A.
Owner RGT UNIV OF CALIFORNIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap